IDXX

415.87

1.58% -6.67

Vorhandelsmarkt: 414.30 -1.57 -0.38%

Idexx Laboratories Inc (IDXX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IDXX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$422.54

Offen:

$422.54

24-Stunden-Volumen:

470.12K

Relative Volume:

0.73

Marktkapitalisierung:

$34.36B

Einnahmen:

$3.90B

Nettoeinkommen (Verlust:

$887.87M

KGV:

38.98

EPS:

10.67

Netto-Cashflow:

$798.08M

1W Leistung:

-1.22%

1M Leistung:

-5.70%

6M Leistung:

-18.74%

1J Leistung:

-22.98%

1-Tages-Spanne:

$415.21

$423.81

1-Wochen-Bereich:

$414.39

$430.15

52-Wochen-Spanne:

$398.50

$548.88

Idexx Laboratories Inc Stock (IDXX) Company Profile

Firmenname

Idexx Laboratories Inc

Sektor

Healthcare (1167)

Branche

Diagnostics & Research (59)

Telefon

(207) 556-0300

Adresse

ONE IDEXX DRIVE, WESTBROOK, ME

Mitarbeiter

Twitter

@idexx

Nächster Verdiensttermin

2025-02-03

Neueste SEC-Einreichungen

IDXX's Discussions on Twitter

Vergleichen Sie IDXX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IDXX Idexx Laboratories Inc	415.87	34.36B	3.90B	887.87M	798.08M	10.67
TMO Thermo Fisher Scientific Inc	500.16	196.14B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	205.85	150.17B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	116.69	33.28B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	177.39	31.62B	15.41B	1.37B	2.11B	7.50

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-02	Eingeleitet	Leerink Partners	Outperform
2024-07-25	Eingeleitet	BTIG Research	Buy
2024-01-30	Herabstufung	Piper Sandler	Overweight → Neutral
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-12-04	Hochstufung	Cleveland Research	Neutral → Buy
2023-08-02	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-07-25	Herabstufung	Stifel	Buy → Hold
2022-07-21	Hochstufung	Goldman	Neutral → Buy
2022-07-12	Eingeleitet	Piper Sandler	Overweight
2022-05-05	Herabstufung	BofA Securities	Buy → Neutral
2022-02-08	Eingeleitet	Atlantic Equities	Overweight
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-07-12	Herabstufung	Guggenheim	Buy → Neutral
2021-02-17	Eingeleitet	Barclays	Overweight
2019-09-09	Eingeleitet	Goldman	Neutral
2019-05-23	Eingeleitet	Guggenheim	Buy
2018-11-02	Bestätigt	BofA/Merrill	Buy
2018-05-07	Bestätigt	Stifel	Buy
2018-01-16	Eingeleitet	Piper Jaffray	Overweight
2017-08-23	Hochstufung	BofA/Merrill	Neutral → Buy
2017-07-28	Hochstufung	CL King	Neutral → Buy
2017-02-03	Herabstufung	Feltl & Co.	Hold → Sell
2016-09-29	Fortgesetzt	BofA/Merrill	Neutral
2016-08-16	Bestätigt	Stifel	Buy
2016-08-03	Hochstufung	Northcoast	Sell → Neutral
2016-07-20	Bestätigt	Canaccord Genuity	Buy
2016-04-19	Bestätigt	Canaccord Genuity	Buy
2016-04-01	Eingeleitet	CL King	Neutral
2016-03-21	Bestätigt	Stifel	Buy
2016-02-04	Eingeleitet	Credit Suisse	Outperform
2015-10-29	Bestätigt	Stifel	Buy
2015-08-28	Herabstufung	Raymond James	Outperform → Mkt Perform
2015-08-13	Bestätigt	Stifel	Buy
2015-07-23	Bestätigt	Canaccord Genuity	Buy

Alle ansehen

Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten

Mar 30, 2025

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - Simply Wall St

Mar 30, 2025

Mar 29, 2025

Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 - Yahoo Finance

Mar 29, 2025

Mar 28, 2025

Form DEF 14A IDEXX LABORATORIES INC For: Dec 31 - StreetInsider.com

Mar 28, 2025

6,931 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Acquired by Howe & Rusling Inc. - MarketBeat

Mar 28, 2025

Mar 26, 2025

Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey

Mar 26, 2025

8 Best Pet Stocks to Buy According to Billionaires - Insider Monkey

Mar 26, 2025

Mar 24, 2025

Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025

IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - Yahoo Finance

Mar 24, 2025

Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025

Mar 18, 2025

Idexx's Economic Moat Remains Solid, but Softer Consumer Confidence Could Weigh on Near Term - Morningstar

Mar 18, 2025

Should You Retain IDEXX Stock in Your Portfolio for Now? - TradingView

Mar 18, 2025

Mar 17, 2025

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To ‘Buy’ (NASDAQ:IDXX) - Seeking Alpha

Mar 17, 2025

Mar 14, 2025

Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Nasdaq

Mar 14, 2025

The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years - Simply Wall St

Mar 14, 2025

Is IDEXX Laboratories Stock Underperforming The Nasdaq? - Barchart

Mar 14, 2025

Mar 13, 2025

Jones Financial Companies Lllp Sells 194 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

Mar 13, 2025

Mar 12, 2025